Posts Tagged ‘FDA’

OHSU’s Erick Turner to present at next Data Jamboree, Dec. 16

Join the OHSU Library and Computational Biology Program for December’s Data Jamboree. This month’s event will focus on the role of open content and data in advancing biomedical research and human health. Erick Turner, M.D., Associate Professor at OHSU and Staff Psychiatrist at the Portland VA Medical Center, will introduce OpenTrialsFDA, a current finalist for the highly competitive Open Science Prize. OpenTrialsFDA is a platform developed by Turner and associates that aims to increase access to and … Read More

OHSU startup Orexigen earns FDA approval

The office of Technology Transfer and Business Development is happy to announce that a drug from  Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition. Contrave has two components: … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives